Eralp, T. N. Et Al. 2024. Combination therapy application of Abemaciclib with Doxorubicin in triple negative breast cancer cell line MDA-MB-231. Cellular and Molecular Biology , vol.70, no.2 , 169-177.

Eralp, T. N., Sevinc, A., & MANSUROĞLU, B., (2024). Combination therapy application of Abemaciclib with Doxorubicin in triple negative breast cancer cell line MDA-MB-231. Cellular and Molecular Biology , vol.70, no.2, 169-177.

Eralp, Tugce, Akin Sevinc, And Banu MANSUROĞLU. "Combination therapy application of Abemaciclib with Doxorubicin in triple negative breast cancer cell line MDA-MB-231," Cellular and Molecular Biology , vol.70, no.2, 169-177, 2024

Eralp, Tugce N. Et Al. "Combination therapy application of Abemaciclib with Doxorubicin in triple negative breast cancer cell line MDA-MB-231." Cellular and Molecular Biology , vol.70, no.2, pp.169-177, 2024

Eralp, T. N. Sevinc, A. And MANSUROĞLU, B. (2024) . "Combination therapy application of Abemaciclib with Doxorubicin in triple negative breast cancer cell line MDA-MB-231." Cellular and Molecular Biology , vol.70, no.2, pp.169-177.

@article{article, author={Tugce Nur Eralp Et Al. }, title={Combination therapy application of Abemaciclib with Doxorubicin in triple negative breast cancer cell line MDA-MB-231}, journal={Cellular and Molecular Biology}, year=2024, pages={169-177} }